Manni Joseph S. reported grant involving 3,500 derivative units of Ceribell, Inc. at $0.00 for $0 on Mar 10, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Revenue Officer
Chief Revenue Officer
Filed May 26, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
3,500Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
3,500Direct
Trade date
Mar 10, 2026Grant
Filed
May 26, 2026, 4:22 PM ET77-day reporting delay
Accession
0001193125-26-239395Code A · Transaction 386295
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 21, 2026Sell1,378$18.00−$24,804Trade 386294
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 77 calendar days after the transaction date.

CBLL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CBLL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +7.2%1w ago −6.7%1d ago −2.8%
Returns since7d −6.9%30d +4.9%90d +27%180d1y

Footnotes in full

F1: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2: Represents a performance-based stock option previously granted to the Reporting Person by the Issuer on April 23, 2024 for an aggregate of 54,472 post-split shares (or 140,000 pre-split shares) of Common Stock, which is subject to annual performance-based vesting conditions for each of the fiscal years ending December 31, 2024, 2025, 2026, and 2027. The performance metrics for the 2024 fiscal year were not satisfied, resulting in the automatic cancellation of that portion of the award. On March 10, 2026, the Board of Directors determined that the performance metrics were partially satisfied for the 2025 fiscal year and approved the vesting of the option as to 3,500 post-split shares. F3: The stock option is fully vested as of March 15, 2026 and is currently exercisable.